1-3 of 3
Manish R. Sharma
Close
Sort by
Journal Articles

A Phase 1, First-in-Human, Dose-Escalation Study of MGD024, a CD123 x CD3 Bispecific Dart® Molecule, in Patients with Relapsed or Refractory CD123-Positive (+) Hematologic Malignancies

Eric S. Winer, Michael Maris, Manish R. Sharma, Patrick Kaminker, Enxu Zhao, Ashley Ward, Andrew L. Sochacki
Journal: Blood
Blood (2022) 140 (Supplement 1): 11753–11754.
https://doi.org/10.1182/blood-2022-159524
Published: 2022
Journal Articles

Treatment of AML Relapse After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Using Low-Dose Azacitidine (AZA).

Alexandre Chiattone, MD, Rima M Saliba, MD, Borje S. Andersson, MD, Sergio Giralt, MD, Manish R Sharma, MD, Gabriela Rondon, MD, Partow Kebriaei, MD, Chitra Hosing, MD, Uday Popat, MD, Simrit Parmar, MD, Gheath Alatrash, DO, PhD, Qaiser Bashir, MD, Julianne J Chen, Carrie Hai-Lai Yuen, MD, Viviane C. Chiattone, RN, Richard E. Champlin, MD, Marcos De Lima, MD
Journal: Blood
Blood (2010) 116 (21): 3445.
https://doi.org/10.1182/blood.V116.21.3445.3445
Published: 2010
Journal Articles

Treatment of FLT3-ITD Positive AML Relapsing After Allogeneic Hematopoietic Stem Cell Transplant (HSCT) with Sorafenib.

Manish R Sharma, MD, Farhad Ravandi, MD, Alexandre Chiattone, MD, Partow Kebriaei, MD, Uday Popat, MD, Sergio Giralt, MD, Qaiser Bashir, MD, Muzaffar H. Qazilbash, MD, Yago Nieto, MD, PhD, Carrie Hai-Lai Yuen, MD, Simrit Parmar, MD, Hagop M. Kantarjian, MD, Jorge Cortes, MD, Tapan Kadia, MD, Gautam Borthakur, MD, Richard E. Champlin, MD, Marcos De Lima, MD
Journal: Blood
Blood (2010) 116 (21): 3471.
https://doi.org/10.1182/blood.V116.21.3471.3471
Published: 2010